Cargando…
Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is a widely available curative option for patients with sickle cell disease (SCD). Our original non-myeloablative haplo-HSCT trial employing post-transplant (PT) cyclophosphamide had a low incidence of GVHD but had high rejection ra...
Autores principales: | Bhat, Deepali K., Olkhanud, Purevdorj B., Gangaplara, Arunakumar, Seifuddin, Fayaz, Pirooznia, Mehdi, Biancotto, Angélique, Fantoni, Giovanna, Pittman, Corinne, Francis, Berline, Dagur, Pradeep K., Saxena, Ankit, McCoy, J. Philip, Pfeiffer, Ruth M., Fitzhugh, Courtney D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669726/ https://www.ncbi.nlm.nih.gov/pubmed/34917079 http://dx.doi.org/10.3389/fimmu.2021.757279 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2021) -
Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs
por: Manjili, Masoud H., et al.
Publicado: (2014) -
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021) -
T‐cell depleted HLA‐haploidentical HSCT in a child with neuromyelitis optica
por: Ceglie, Giulia, et al.
Publicado: (2019) -
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)